Search research articles
Contact Us
Filters
Showing results (121-130 of 261) with videos related to
Page
of 27
Sort By:
Lancet (London, England)
|
September 22, 1998
Open debate on hormone-replacement therapy
P Boyle, R Horton, G Radda, et al.
Cancer Research
|
April 1, 1994
Prospects of chemoprevention of human cancers with the synthetic retinoid fenretinide
A Costa, F Formelli, F Chiesa, et al.
Tumori
|
December 10, 1999
Accrual issues for chemoprevention trials: the example of the 4-HPR study for the prevention of contralateral breast cancer
T Camerini, G De Palo, L Mariani, et al.
Archives of Internal Medicine
|
September 9, 1996
Effect of tamoxifen on measurements of hemostasis in healthy women
P M Mannucci, D Bettega, V Chantarangkul, et al.
Minerva Ginecologica
|
November 1, 1982
[Conservative surgery of breast carcinoma of small dimensions]
U Veronesi, M del Vecchio, A Costa, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 26, 2003
Measuring progress against cancer in Europe: has the 15% decline targeted for 2000 come about?
P Boyle, A d'Onofrio, P Maisonneuve, et al.
Breast Cancer Research and Treatment
|
January 1, 1985
Ten-year experience with CMF-based adjuvant chemotherapy in resectable breast cancer
G Bonadonna, P Valagussa, A Rossi, et al.
Lancet (London, England)
|
February 1, 2003
Overview of the main outcomes in breast-cancer prevention trials
J Cuzick, T Powles, U Veronesi, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer
|
January 1, 1982
Multimodal therapy with CMF in resectable breast cancer with positive axillary nodes: the Milan Institute experience
G Bonadonna, P Valagussa, A Rossi, et al.
Journal of the National Cancer Institute. Monographs
|
January 1, 1992
Chemoprevention of breast cancer with retinoids
U Veronesi, G De Palo, A Costa, et al.
Page
of 27
Search research articles
Search
Showing results (121-130 of 261) with videos related to
Sort By:
Page
of 27
Lancet (London, England)
|
September 22, 1998
Open debate on hormone-replacement therapy
P Boyle, R Horton, G Radda, et al.
Cancer Research
|
April 1, 1994
Prospects of chemoprevention of human cancers with the synthetic retinoid fenretinide
A Costa, F Formelli, F Chiesa, et al.
Tumori
|
December 10, 1999
Accrual issues for chemoprevention trials: the example of the 4-HPR study for the prevention of contralateral breast cancer
T Camerini, G De Palo, L Mariani, et al.
Archives of Internal Medicine
|
September 9, 1996
Effect of tamoxifen on measurements of hemostasis in healthy women
P M Mannucci, D Bettega, V Chantarangkul, et al.
Minerva Ginecologica
|
November 1, 1982
[Conservative surgery of breast carcinoma of small dimensions]
U Veronesi, M del Vecchio, A Costa, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 26, 2003
Measuring progress against cancer in Europe: has the 15% decline targeted for 2000 come about?
P Boyle, A d'Onofrio, P Maisonneuve, et al.
Breast Cancer Research and Treatment
|
January 1, 1985
Ten-year experience with CMF-based adjuvant chemotherapy in resectable breast cancer
G Bonadonna, P Valagussa, A Rossi, et al.
Lancet (London, England)
|
February 1, 2003
Overview of the main outcomes in breast-cancer prevention trials
J Cuzick, T Powles, U Veronesi, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer
|
January 1, 1982
Multimodal therapy with CMF in resectable breast cancer with positive axillary nodes: the Milan Institute experience
G Bonadonna, P Valagussa, A Rossi, et al.
Journal of the National Cancer Institute. Monographs
|
January 1, 1992
Chemoprevention of breast cancer with retinoids
U Veronesi, G De Palo, A Costa, et al.
Page
of 27